Resources & Insights

Alzheimer’s Disease & Decentralized Clinical Trials

Should your Alzheimer’s disease clinical trial be decentralized or include virtual aspects? In this article, we discuss potential benefits.

September 27, 2022
View the Post

How to Select Data Monitoring Committee (DMC) Members

Working to select members for a data monitoring committee? Explore criteria for member selection, training, and how to select a Chairperson.

June 8, 2022
View the Post

Supporting Blood Cancer Clinical Trials: Predicting Study Challenges

What challenges should teams conducting blood cancer clinical trials anticipate? Learn more about common obstacles and how to overcome them.

May 26, 2022
View the Post

CRO Selection Checklist: 27 Things to Know

Selecting a CRO is a complicated process. Start your search with our free CRO Selection Checklist, detailing 27 things to look out for.

May 13, 2022
View the Post

History of Data Monitoring Committees

Learn more about the evolution and history of data monitoring committees, from the 1960s to today.

May 3, 2022
View the Post

Site Feasibility: Maximizing Enrollment Potential

Site Feasibility: Learn how to increase your study’s speed to first patient in and maximize enrollment potential.

April 29, 2022
View the Post

4 Key Considerations for Managing & Monitoring Neurology Clinical Trials

Neurology studies are highly complex. Explore the following 4 key considerations to successfully manage and monitor neurology trials.

January 6, 2022
View the Post

PharPoint Gives Back 2021 Campaign

Supporting our Local NC Communities: PharPoint Gives Back 2021 Each year the PharPoint team arranges an end-of-year giving back campaign. This year, we’re thrilled to have raised over $1,300 for the Interfaith Food Shuttle in a virtual food drive. We’re delighted to have surpassed the goal we set for this year. We’re incredibly grateful for...
December 17, 2021
View the Post

Ensuring Consistency in RECIST 1.1 Reads

RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.

December 15, 2021
View the Post

CRO Red Flags: Signs Your Study is at Risk & Considerations for Selecting a Rescue Partner

Certain red flags sometimes necessitate a rescue to “save” a clinical trial from an underperforming CRO. Here’s what to look out for.

December 6, 2021
View the Post